Inhibition of HIV type 1 replication by human T lymphotropic virus types 1 and 2 tax proteins in vitro

AIDS Research and Human Retroviruses

Volumn 29, Issue 7, 2013, Pages 1061-1067

  Barrios, Christy S ^a,b   Castillo, Laura ^a,b   Giam, Chou Zen ^c   Wu, Li ^d   Beilke, Mark A ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; TAX 1 PROTEIN; TAX 2 PROTEIN; TAX PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SUPERNATANT; VIRUS REPLICATION;

CHEMOKINES, CC; COINFECTION; GENE PRODUCTS, TAX; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HTLV-I INFECTIONS; HTLV-II INFECTIONS; HUMANS; LEUKOCYTES, MONONUCLEAR; VIRAL INTERFERENCE; VIRUS REPLICATION;

EID: 84879137482     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2013.0027     Document Type: Article

References (24)

1. WHO, UNAIDS, UNICEF. GLOBAL HIV/AIDS RESPONSE-Epidemic update and health sector progress towards Universal Access-Progress Report 2011. http://www .who.int/hiv/pub/progress-report2011/summary-en.pdf.
2. de Thé G and Kazanji M: An HTLV-I/II vaccine: From animal models to clinical trials? J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:S191-S198.
3. Beilke MA, Theall KP, O'Brien M, Clayton JL, Benjamin SM, Winsor EL, and Kissinger PJ: Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2. Clin Infect Dis 2004;39: 256-263.
4. Araugo A, Sheehy N, Takahashi H, and Hall WW: Concomitant infections with human immunodeficiency virus type 1 and human T-lymphotropic virus types 1 and 2. In: Polymicrobial Diseases (Brogden KA and Guthmiller JM, Eds.). ASM Press, Washington, DC, 2002, pp. 75-97.
5. Casseb J, Posada-Vergara MP, Montanheira P, Fukumori LMI, Olah I, Smid J, Duarto AJ, and Penaiva de Oliveira AC: T CD4+ cell counts among patients co-infected with human immunodeficiency virus type 1 (HIV-1) and human T-cell leukemia virus type 1 (HTLV-1): High prevalence of tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM). Revist Instit Med Trop Sao Paulo 2007;49:231-233.
6. Beilke MA, Japa S, Moeller-Hadi C, and Martin-Schild S: Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients. Clin Infect Dis 2005;41:e57-e63.
7. Turci M, Pilotti E, Ronzi P, Magnani G, Boschini A, Parisi SG, Zipeto D, Lisa A, Casoli C, and Bertazzoni U: Coinfection with HIV-1 and human T-cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS. J Acquir Immune Defic Syndr 2006; 41:100-106.
8. Bertazzoni U, Turci M, Avesani F, DiiGennaro G, Bidoia C, and Romanelli MG: Intracellular localization and cellular factors interaction of HTLV-1 and HTLV-2 Tax proteins: Similarities and functional differences. Viruses 2011,3:541-560.
9. Lewis MJ, Gautier VW, Wang XP, Kaplan MH, and Hall WW: Spontaneous production of CC-chemokines by individuals infected with human T lymphoptropic virus type II (HTLV-II) alone and HTLV-II/HIV-1 coinfected individuals. J Immunol 2000;165:4127-4132.
10. Barrios CS, Abuerreish M, Castillo L, Lairmore MD, Giam C-Z, and Beilke MA: Recombinant human T-cell leukemia virus types 1 and 2 Tax proteins induce high levels of CCchemokines and downregulate CCR5 in human peripheral blood mononuclear cells. Viral Immunol 2011;24:429-439.
11. Balistrieri G, Barrios C, Castillo L, Umunakwe TC, Giam CZ, Zhi H, and Beilke MA: Induction of CC-chemokines with antiviral function in macrophages by the human T lymphotropic virus type 2 transactivating protein, Tax2. Viral Immunol 2013;26:3-12.
12. Dong C, Janas AM, Wang JH, Olson WJ, and Wu L: Characterization of human immunodeficiency virus type 1 replication in immature and mature dendritic cells reveals dissociable cis-and trans-infection. J Virol 2007;81:11352-11362.
13. Rende F, Cavallari I, Romanelli MG, Diani E, Bertazzoni U, and Ciminale V: Comparison of the genetic organization, expression strategies and oncogenic potential of HTLV-1 and HTLV-2. Leuk Res Treat 2012;2012:1-14.
14. Moriuchi H, Moriuchi M, and Fauci AS: Factors secreted by human T lymphotropic virus type I (HTLV-I)-infected cells can enhance or inhibit replication of HIV-1 in HTLV-Iuninfected cells: implications for in vivo coinfection with HTLV-I and HIV-1. J Exp Med 1998;187:1689-1697.
15. Masuda T, Planelles V, Krogstad P, and Chen IS: Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: Unusual phenotype of mutants in the zinc finger-like domain. J Virol 1995;69:6687-6696.
16. Butler SL, Hansen MS, and Bushman FD: A quantitative assay for HIV DNA integration in vivo. Nat Med 2001;7:631-634.
17. Bovolenta C, Pilotti E, Mauri M, Panzeri B, Sassi M, Dall'Aglio P, Bertazzoni U, Poli G, and Casoli C: Retroviral interference on STAT activation in individuals coinfected with human T cell leukemia virus type 2 and HIV-1. J Immunol 2002;169:4443-4449.
18. Coakley E, Petropoulos CJ, and Whitcomb JM: Assessing chemokine co-receptor usage in HIV-1. Curr Opin Infect Dis 2005;18:9-15.
19. Sullivan YB, Landay AL, Zack JA, and Kitchen SG: Upregulation of CD4 on CD8+ T cells: CD4dimCD8bright T cells constitute an activated phenotype of CD8+ T cells. Immunology 2001;103:270-280.
20. Zhang W, Chaloner K, Tillmann HL, Williams CF, and Stapleton JT: Effect of early and late GB virus C viraemia on survival of HIV-infected individuals: A meta-analysis. HIV Med 2006;7:173-180.
21. Xiang J, George SL, Wunschmann S, Chang Q, Klinzman D, and Stapleton JT: Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1a, MIP-1b, SDF-1. Lancet 2004;363:2040-2046.
22. Xiang J, Sathar MA, McLinden JH, Klinzman D, Chang Q, and Stapleton JT: South African GB virus C isolates: Interactions between genotypes 1 and 5 isolates and HIV. J Infect Dis 2005;192:1267-1272.
23. Moss WJ, Ryon JJ, Monze M, Cutts F, Quinn TC, and Griffin DE: Suppression of human immunodeficiency virus replication during acute measles. J Infect Dis 2002;185:1035-1042.
24. García M, Yu XF, Griffin DE, and Moss WJ: In vitro suppression of human immunodeficiency virus type 1 replication by measles virus. J Virol 2005;79:9197-9205.